Investigational multitargeted kinase inhibitors in development for head and neck neoplasms
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2019.1581172
Abstract: ABSTRACT Introduction: Despite advances in treatment, head and neck squamous cell carcinoma (HNSCC) survival rates remain stagnant. Current treatment is associated with significant toxicities and includes chemotherapy, radiation, surgery, and few targeted treatments. Targeted treatments,… read more here.
Keywords: kinase inhibitors; targeted treatments; multitargeted kinase; head neck ... See more keywords
Development and validation of targeted treatments for the rare tumor syndrome infantile myofibromatosis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e22519
Abstract: e22519Background: Infantile myofibromatosis (IMF; MIM 228550) is an autosomal dominant disorder characterized by fibroblastic tumors of skin, muscles, viscera and bones. Tumor growth may begin duri... read more here.
Keywords: validation targeted; development validation; infantile myofibromatosis; treatments rare ... See more keywords